The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer

Interactive Cardiovascular and Thoracic Surgery

Volumn 16, Issue 3, 2013, Pages 270-273

  Takenaka, Tomoyoshi ^a   Katsura, Masakazu ^a   Shikada, Yasunori ^a   Tsukamoto, Syuichi ^a   Takeo, Sadanori ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Cardiovascular comorbidity; Non small cell lung cancer; Surgery; Survival

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; ATELECTASIS; BRONCHOPLEURAL FISTULA; CANCER PROGNOSIS; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874327619     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs489     Document Type: Article

References (18)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2011;41:139-47.
3. Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004; 59:602-7.
4. Takamochi K, Oh S, Matsuoka J, Suzuki K. Risk factors for morbidity after pulmonary resection for lung cancer in younger and elderly patients. Interact CardioVasc Thorac Surg 2011;12:739-43.
5. Licker M, de Perrot M, Höhn L, Tschopp JM, Robert J, Frey JG et al. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg 1999; 15:314-9.
6. Licker M, Spiliopoulos A, Frey JG, Robert J, Höhn L, de Perrot M et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 2002; 121:1890-7.
7. Ambrogi V, Pompeo E, Elia S, Pistolese GR, Mineo TC. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardiothorac Surg 2003;23:811-7.
8. Hollaus PH, Wilfing G, Wurnig PN, Pridun NS. Risk factors for the development of postoperative complications after bronchial sleeve resection for malignancy: a univariate and multivariate analysis. Ann Thorac Surg 2003;75:966-72.
9. Mishra PK, Pandey R, Shackcloth MJ, McShane J, Grayson AD, Carr MH et al. Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer. Eur J Cardiothorac Surg 2009;35:439-43.
10. Myrdal G, Gustafsson G, Lambe M, Hörte LG, Ståhle E. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur J Cardiothorac Surg 2001;20:694-9.
11. Moro-Sibilot D, Aubert A, Diab S, Lantuejoul S, Fourneret P, Brambilla E et al. Comorbidities and Charlson score in resected stage I non small cell lung cancer. Eur Respir J 2005;26:480-6.
12. JCS Joint Working Group. Guidelines for perioperative cardiovascular evaluation and management for noncardiac surgery ( JCS 2008)-digest version. Circ J 2011;75:989-1009.
13. World Health Organization. Histological Typing of Lung and Pleural Tumors, 3rd edn. Geneva, Switzerland: Springer-Verlag, 1999.
14. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R et al., International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14.
15. Rueth NM, Parsons HM, Habermann EB, Groth SS, Virnig BA, Tuttle TM et al. Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population. J Thorac Cardiovasc Surg 2012;143: 1314-23.
16. Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008;135:247-54.
17. Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M et al., Japanese Joint Committee for Lung Cancer Registration. Japanese lung cancer registry study of 11 663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 2011;6:1229-35.
18. Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y et al., Japanese Joint Committee of Lung Cancer Registry. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol 2009;4:1247-53.